Uchimoto, Taizo http://orcid.org/0000-0003-4157-1929
Tsuchida, Shuya
Komura, Kazumasa
Fukuokaya, Wataru
Adachi, Takahiro
Hirasawa, Yosuke
Hashimoto, Takeshi
Yoshizawa, Atsuhiko
Saruta, Masanobu
Hashimoto, Mamoru
Higashio, Takuya
Matsuda, Takuya
Nishimura, Kazuki
Tsujino, Takuya
Nakamura, Ko
Fukushima, Tatsuo
Nishio, Kyosuke
Yamamoto, Shutaro
Iwatani, Kosuke
Urabe, Fumihiko
Mori, Keiichiro
Yanagisawa, Takafumi
Tsuduki, Shunsuke
Takahara, Kiyoshi
Inamoto, Teruo
Miki, Jun
Fujita, Kazutoshi
Kimura, Takahiro
Ohno, Yoshio
Shiroki, Ryoichi
Uemura, Hirotsugu
Azuma, Haruhito
Funding for this research was provided by:
Japan Society for the Promotion of Science (21H03070)
SGH Foundation
Kenzo Suzuki Memorial Foundation
Naito Foundation
Japanese Urological Association
Article History
Accepted: 26 February 2024
First Online: 28 March 2024
Declarations
:
: Kazumasa Komura was partially supported by Grant-in-Aid No. 21H03070 (Japan Society for the Promotion of Science: JSPS), the Kenzo Suzuki Memorial Foundation, the SGH Foundation, the Naito Memorial Foundation, and the Cancer Translational Research Foundation of Japanese Urological Association (JUA).
: Taizo Uchimoto, Shuya Tsuchida, Kazumasa Komura, Wataru Fukuokaya, Takahiro Adachi, Yosuke Hirasawa, Takeshi Hashimoto, Atsuhiko Yoshizawa, Masanobu Saruta, Mamoru Hashimoto, Takuya Higashio, Takuya Matsuda, Kazuki Nishimura, Takuya Tsujino, Ko Nakamura, Tatsuo Fukushima, Kyosuke Nishio, Shutaro Yamamoto, Kosuke Iwatani, Fumihiko Urabe, Keiichiro Mori, Takafumi Yanagisawa, Shunsuke Tsuduki, Kiyoshi Takahara, Teruo Inamoto, Jun Miki, Kazutoshi Fujita, Takahiro Kimura, Yoshio Ohno, Ryoichi Shiroki, Hirotsugu Uemura, and Haruhito Azuma declare that they have no conflicts of interest that might be relevant to the contents of this manuscript.
: This study was approved by the Institutional Review Board (IRB) from Osaka Medical and Pharmaceutical University (approval number: RIN-750-2571, approved on 24th January 2020). This observational study adhered to ethical principles aligned with the Declaration of Helsinki, the International Conference on Harmonisation’s Good Clinical Practice guidelines, Good Pharmacoepidemiology Practices, and relevant laws for noninterventional and observational studies.
: Not applicable.
: Not applicable.
: The data from this study can be accessed by academic and commercial partners upon a reasonable request, subject to IRB approval and a data use agreement. For further details or to reanalyze the study’s data, contact the Lead Contact at kazumasa.komura@ompu.ac.jp.
: Not applicable.
: T. Uchimoto: conceptualization, data curation, analysis, investigation, methodology, software, visualization, writing original draft, supervision. S. Tsuchida: data curation, analysis, investigation, methodology, software, visualization. K. Komura: data curation, investigation, investigation, writing the original draft, supervision. W. Fukuokaya: investigation, data curation, validation. A. Adachi: validation, methodology. Y. Hirasawa: methodology, validation. T. Hashimoto: methodology, validation. A. Yoshizawa: data curation. M. Saruta: data curation. M. Hashimoto: analysis. T. Higashio: data curation, analysis. T. Matsuda: investigation. K. Nishimura: data curation. T. Tsujino: methodology, data curation. K. Nakamura: investigation. T. Fukushima: data curation, analysis. K. Nishio: validation. S. Yamamoto: data curation. K. Iwatani: investigation, supervision. F. Urabe: investigation, validation, supervision. K. Mori: methodology, data analysis. T. Yanagisawa: investigation. S. Tsuduki: writing original draft, review. K, Takahara: editing, supervision. T. Inamoto: data curation. J. Miki: data curation, analysis. K. Fujita: review and editing, supervision. T. Kimura: investigation, validation, supervision. Y. Ohno: supervision. R. Shiroki: supervision. H. Uemura: supervision. H. Azuma: supervision.